Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Non-Current Assets (2021 - 2025)

Historic Non-Current Assets for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to $2.0 billion.

  • Rxo's Non-Current Assets fell 554.22% to $2.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 billion, marking a year-over-year decrease of 554.22%. This contributed to the annual value of $2.0 billion for FY2025, which is 554.22% down from last year.
  • Latest data reveals that Rxo reported Non-Current Assets of $2.0 billion as of Q4 2025, which was down 554.22% from $2.0 billion recorded in Q3 2025.
  • In the past 5 years, Rxo's Non-Current Assets ranged from a high of $2.1 billion in Q3 2024 and a low of $985.0 million during Q4 2021
  • For the 5-year period, Rxo's Non-Current Assets averaged around $1.4 billion, with its median value being $1.0 billion (2023).
  • In the last 5 years, Rxo's Non-Current Assets surged by 11158.42% in 2024 and then crashed by 641.09% in 2025.
  • Rxo's Non-Current Assets (Quarter) stood at $985.0 million in 2021, then rose by 1.73% to $1.0 billion in 2022, then rose by 2.69% to $1.0 billion in 2023, then surged by 101.65% to $2.1 billion in 2024, then fell by 5.54% to $2.0 billion in 2025.
  • Its Non-Current Assets was $2.0 billion in Q4 2025, compared to $2.0 billion in Q3 2025 and $2.0 billion in Q2 2025.